Evan Mizerak

Company: Amylyx Pharmaceuticals Corp.

Job title: Lead of Preclinical Research

Seminars:

Preclinical Development of AMX0114: An Antisense Oligonucleotide Inhibitor of Calpain-2 2:30 pm

Calpain-2 and axonal degeneration in neurodegenerative diseases In silico design and screening of novel ASOs to inhibit calpain-2 Preclinical efficacy studies of AMX0114 in models of ALSRead more

day: Conference Day One